Ongoing challenges of a global international patient assistance program
The Glivec International Patient Assistance Program (GIPAP™) that is supported by Novartis Oncology provides Glivec (imatinib), an innovative oral therapy for chronic myelogenous leukemia and gastrointestinal stromal tumours, at no cost to patients in developing countries who could otherwise not aff...
Saved in:
Main Authors: | Stephanie Lassarat, S. Jootar |
---|---|
Other Authors: | Global Patient Access |
Format: | Article |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/23017 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
The ongoing D-lemma of Vitamin D supplementation for nonskeletal health and bone health
by: Nipith Charoenngam, et al.
Published: (2020) -
Population parameters underlying an ongoing soft sweep in southeast asian malaria parasites
by: Timothy J.C. Anderson, et al.
Published: (2018) -
Feasibility, Challenges, and Benefits of Global Antimicrobial Resistance Surveillance System Implementation: Results from a Multicenter Quasi-Experimental Study
by: Sirijatuphat R.
Published: (2023) -
Edmonton Symptom Assessment Scale Time Duration of Self-Completion Versus Assisted Completion in Patients with Advanced Cancer: A Randomized Comparison
by: Angelique Wong, et al.
Published: (2020) -
Outcome of the gynecologic oncology patients surveillance network program
by: Prapaporn Suprasert, et al.
Published: (2018)